$41.22
0.791.95%
At close: -
$41.22
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Cytokinetics Analyst Ratings and Price Targets | NASDAQ:CYTK | Benzinga
Cytokinetics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Cytokinetics Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
HC Wainwright & Co.
B of A Securities
JMP Securities
Needham
1calculated from analyst ratings
Analyst Ratings for Cytokinetics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/24/2025 | Buy Now | — | Barclays | Gena Wang50% | → $55 | Initiates | → Overweight | Get Alert |
| 04/21/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 04/15/2025 | Buy Now | — | B of A Securities | Jason Zemansky72% | $62 → $54 | Maintains | Neutral | Get Alert |
| 04/15/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 04/10/2025 | Buy Now | — | JMP Securities | Jason Butler52% | $78 → $78 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/08/2025 | Buy Now | — | Needham | Serge Belanger68% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 04/04/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 04/03/2025 | Buy Now | — | Citizens Capital Markets | Jason Butler52% | $78 → $78 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/28/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 02/13/2025 | Buy Now | — | Morgan Stanley | Jeffrey Hung50% | $70 → $67 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/07/2025 | Buy Now | — | Citigroup | David Lebowitz52% | → $86 | Initiates | → Buy | Get Alert |
| 02/07/2025 | Buy Now | — | JMP Securities | Jason Butler52% | $78 → $78 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/06/2025 | Buy Now | — | Needham | Serge Belanger68% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 01/22/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 01/22/2025 | Buy Now | — | Stifel | James Condulis58% | → $80 | Initiates | → Buy | Get Alert |
| 01/21/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 01/14/2025 | Buy Now | — | JMP Securities | Jason Butler52% | $78 → $78 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/14/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 01/10/2025 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | — | Reiterates | Buy → Buy | Get Alert |
| 12/23/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 12/20/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 12/18/2024 | Buy Now | — | RBC Capital | Leonid Timashev39% | $80 → $82 | Maintains | Outperform | Get Alert |
| 12/03/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 12/02/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 12/02/2024 | Buy Now | — | Needham | Serge Belanger68% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 11/21/2024 | Buy Now | — | Mizuho | Salim Syed43% | $99 → $103 | Maintains | Outperform | Get Alert |
| 11/20/2024 | Buy Now | — | Needham | Serge Belanger68% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 11/19/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 11/18/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 11/11/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 11/08/2024 | Buy Now | — | RBC Capital | Leonid Timashev39% | → $80 | Initiates | → Outperform | Get Alert |
| 11/07/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 10/18/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
| 10/17/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 10/17/2024 | Buy Now | — | Needham | Serge Belanger68% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 10/09/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $90 → $120 | Maintains | Buy | Get Alert |
| 09/30/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 09/20/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 09/09/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
| 09/09/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2024 | Buy Now | — | JP Morgan | Tessa Romero60% | $65 → $71 | Maintains | Overweight | Get Alert |
| 09/04/2024 | Buy Now | — | JMP Securities | Jason Butler52% | $78 → $78 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/03/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 09/03/2024 | Buy Now | — | Needham | Serge Belanger68% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 08/13/2024 | Buy Now | — | Goldman Sachs | Paul Choi60% | $85 → $60 | Downgrade | Buy → Neutral | Get Alert |
| 08/12/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2024 | Buy Now | — | Needham | Serge Belanger68% | $72 → $72 | Reiterates | Buy → Buy | Get Alert |
| 06/24/2024 | Buy Now | — | JP Morgan | Tessa Romero60% | $77 → $65 | Maintains | Overweight | Get Alert |
| 06/17/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 06/04/2024 | Buy Now | — | B. Riley Securities | Mayank Mamtani70% | $122 → $92 | Maintains | Buy | Get Alert |
| 05/31/2024 | Buy Now | — | JMP Securities | Jason Butler52% | $78 → $78 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/29/2024 | Buy Now | — | Truist Securities | Srikripa Devarakonda44% | $86 → $70 | Maintains | Buy | Get Alert |
| 05/28/2024 | Buy Now | — | JMP Securities | Jason Butler52% | $106 → $78 | Maintains | Market Outperform | Get Alert |
| 05/23/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $94 → $90 | Maintains | Buy | Get Alert |
| 05/23/2024 | Buy Now | — | B of A Securities | Jason Zemansky72% | $70 → $60 | Maintains | Neutral | Get Alert |
| 05/23/2024 | Buy Now | — | Barclays | Carter Gould59% | $100 → $95 | Maintains | Overweight | Get Alert |
| 05/23/2024 | Buy Now | — | Raymond James | Sean McCutcheon12% | $92 → $70 | Maintains | Outperform | Get Alert |
| 05/23/2024 | Buy Now | — | Needham | Serge Belanger68% | $108 → $72 | Maintains | Buy | Get Alert |
| 05/14/2024 | Buy Now | — | B of A Securities | Jason Zemansky72% | $75 → $70 | Maintains | Neutral | Get Alert |
| 05/14/2024 | Buy Now | — | JMP Securities | Jason Butler52% | $106 → $106 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/14/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $94 → $94 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2024 | Buy Now | — | Needham | Serge Belanger68% | $108 → $108 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $94 → $94 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | — | Needham | Serge Belanger68% | $108 → $108 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | — | JMP Securities | Jason Butler52% | $110 → $106 | Maintains | Market Outperform | Get Alert |
| 05/09/2024 | Buy Now | — | Oppenheimer | Justin Kim37% | $107 → $106 | Maintains | Outperform | Get Alert |
| 05/08/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $94 → $94 | Reiterates | Buy → Buy | Get Alert |
| 04/09/2024 | Buy Now | — | Needham | Serge Belanger68% | → $108 | Reiterates | Buy → Buy | Get Alert |
| 04/08/2024 | Buy Now | — | Truist Securities | Srikripa Devarakonda44% | $86 → $86 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2024 | Buy Now | — | JP Morgan | Tessa Romero60% | $78 → $77 | Maintains | Overweight | Get Alert |
| 03/06/2024 | Buy Now | — | Mizuho | Salim Syed43% | $103 → $99 | Maintains | Buy | Get Alert |
| 03/04/2024 | Buy Now | — | Oppenheimer | Justin Kim37% | → $107 | Reiterates | Outperform → Outperform | Get Alert |
| 02/28/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $94 → $94 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2024 | Buy Now | — | Needham | Serge Belanger68% | $108 → $108 | Reiterates | Buy → Buy | Get Alert |
| 01/24/2024 | Buy Now | — | UBS | Ashwani Verma42% | $61 → $92 | Downgrade | Buy → Neutral | Get Alert |
| 01/22/2024 | Buy Now | — | Mizuho | Salim Syed43% | $80 → $103 | Maintains | Buy | Get Alert |
| 01/08/2024 | Buy Now | — | B. Riley Securities | Mayank Mamtani70% | $66 → $122 | Maintains | Buy | Get Alert |
| 01/05/2024 | Buy Now | — | Morgan Stanley | Jeffrey Hung50% | $60 → $90 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/28/2023 | Buy Now | — | Truist Securities | Srikripa Devarakonda44% | $60 → $86 | Maintains | Buy | Get Alert |
| 12/28/2023 | Buy Now | — | Raymond James | Sean McCutcheon12% | $63 → $92 | Maintains | Outperform | Get Alert |
| 12/27/2023 | Buy Now | — | Needham | Serge Belanger68% | $60 → $108 | Maintains | Buy | Get Alert |
| 12/27/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $58 → $94 | Maintains | Buy | Get Alert |
| 11/09/2023 | Buy Now | — | Goldman Sachs | Paul Choi60% | → $50 | Initiates | → Buy | Get Alert |
| 11/07/2023 | Buy Now | — | B. Riley Securities | Mayank Mamtani70% | → $66 | Initiates | → Buy | Get Alert |
| 11/01/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | → $58 | Reiterates | Buy → Buy | Get Alert |
| 10/20/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | $49 → $58 | Maintains | Buy | Get Alert |
| 10/20/2023 | Buy Now | — | Needham | Serge Belanger68% | → $60 | Reiterates | Buy → Buy | Get Alert |
| 10/09/2023 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | $59 → $65 | Maintains | Overweight | Get Alert |
| 10/09/2023 | Buy Now | — | JMP Securities | Jason Butler52% | → $71 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/22/2023 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | → $59 | Reiterates | Overweight → Overweight | Get Alert |
| 08/15/2023 | Buy Now | — | SVB Leerink | Roanna Ruiz34% | → $58 | Initiates | → Outperform | Get Alert |
| 08/04/2023 | Buy Now | — | Needham | Serge Belanger68% | → $60 | Reiterates | → Buy | Get Alert |
| 08/04/2023 | Buy Now | — | Morgan Stanley | Jeffrey Hung50% | $60 → $60 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | → $49 | Reiterates | Buy → Buy | Get Alert |
| 06/22/2023 | Buy Now | — | Morgan Stanley | Jeffrey Hung50% | → $60 | Reiterates | → Overweight | Get Alert |
| 06/20/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | → $49 | Reiterates | Buy → Buy | Get Alert |
| 05/22/2023 | Buy Now | — | JMP Securities | Jason Butler52% | $71 → $71 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/22/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis45% | → $49 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2023 | Buy Now | — | Oppenheimer | Justin Kim37% | → $54 | Reiterates | Outperform → Outperform | Get Alert |
| 05/05/2023 | Buy Now | — | Goldman Sachs | Madhu Kumar72% | $48 → $53 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Cytokinetics (CYTK) stock?
The latest price target for Cytokinetics (NASDAQ:CYTK) was reported by Barclays on April 24, 2025. The analyst firm set a price target for $55.00 expecting CYTK to rise to within 12 months (a possible 33.43% upside). 67 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cytokinetics (CYTK)?
The latest analyst rating for Cytokinetics (NASDAQ:CYTK) was provided by Barclays, and Cytokinetics initiated their overweight rating.
When was the last upgrade for Cytokinetics (CYTK)?
The last upgrade for Cytokinetics Inc happened on February 13, 2025 when Morgan Stanley raised their price target to $67. Morgan Stanley previously had an equal-weight for Cytokinetics Inc.
When was the last downgrade for Cytokinetics (CYTK)?
The last downgrade for Cytokinetics Inc happened on August 13, 2024 when Goldman Sachs changed their price target from $85 to $60 for Cytokinetics Inc.
When is the next analyst rating going to be posted or updated for Cytokinetics (CYTK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cytokinetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cytokinetics was filed on April 24, 2025 so you should expect the next rating to be made available sometime around April 24, 2026.
Is the Analyst Rating Cytokinetics (CYTK) correct?
While ratings are subjective and will change, the latest Cytokinetics (CYTK) rating was a initiated with a price target of $0.00 to $55.00. The current price Cytokinetics (CYTK) is trading at is $41.22, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
